LY6/PLAUR domain containing 3 (LYPD3) maintains melanoma cell stemness and mediates an immunosuppressive microenvironment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LY6/PLAUR domain containing 3 (LYPD3) maintains melanoma cell stemness and mediates an immunosuppressive microenvironment
Authors
Keywords
-
Journal
Biology Direct
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1186/s13062-023-00424-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
- (2023) Satoshi Muto et al. Biomedicines
- S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy
- (2022) Jianjie Li et al. Nature Communications
- LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia
- (2022) Tingting Hu et al. Frontiers in Genetics
- Construction and Validation of a Ferroptosis-Related Prognostic Signature for Melanoma Based on Single-Cell RNA Sequencing
- (2022) Yating Liu et al. Frontiers in Cell and Developmental Biology
- Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1
- (2022) Xueyan Zang et al. Molecular Cancer
- Mechanism of the cadherin-catenin F-actin catch bond interaction
- (2022) Amy Wang et al. eLife
- 9-Gene Signature Correlated With CD8+ T Cell Infiltration Activated by IFN-γ: A Biomarker of Immune Checkpoint Therapy Response in Melanoma
- (2021) Kexin Yan et al. Frontiers in Immunology
- Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
- (2021) Lili Mao et al. Frontiers in Immunology
- Immune evasion by cancer stem cells
- (2021) Hiroyuki Tsuchiya et al. Regenerative Therapy
- Wnt signaling pathway in cancer immunotherapy
- (2021) Yang Zhou et al. CANCER LETTERS
- Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
- (2021) Golnaz Morad et al. CELL
- Melanoma Risk Factors and Prevention
- (2021) William W. Dzwierzynski CLINICS IN PLASTIC SURGERY
- HIF-1–regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation
- (2021) Xiaoxu Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated Expression of LYPD3 Is Associated with Lung Adenocarcinoma Carcinogenesis and Poor Prognosis
- (2020) Ping Hu et al. DNA AND CELL BIOLOGY
- Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
- (2020) Vera Petrova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
- (2020) Jackie E. Bader et al. MOLECULAR CELL
- The tumor microenvironment
- (2020) Nicole M. Anderson et al. CURRENT BIOLOGY
- EMT, cancer stem cells and autophagy; The three main axes of metastasis
- (2020) Ghader Babaei et al. BIOMEDICINE & PHARMACOTHERAPY
- Overcoming Immune Evasion in Melanoma
- (2020) Kevinn Eddy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical and Therapeutic Implications of Cancer Stem Cells
- (2019) Michael F. Clarke NEW ENGLAND JOURNAL OF MEDICINE
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms
- (2019) Peter Valent et al. SEMINARS IN CANCER BIOLOGY
- Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
- (2019) Monica Marzagalli et al. SEMINARS IN CANCER BIOLOGY
- S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma
- (2019) Mao Huang et al. Frontiers in Immunology
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
- (2018) Shrujal Baxi et al. BMJ-British Medical Journal
- Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
- (2018) Shrujal Baxi et al. BMJ-British Medical Journal
- Evolution and diversity of cadherins and catenins
- (2017) Ismail Sahin Gul et al. EXPERIMENTAL CELL RESEARCH
- Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
- (2017) Jörg Willuda et al. MOLECULAR CANCER THERAPEUTICS
- Immune Checkpoint Inhibitors: Basics and Challenges
- (2017) Bin Li et al. CURRENT MEDICINAL CHEMISTRY
- Cancer Stem Cells: Basic Concepts and Therapeutic Implications
- (2016) Dany Nassar et al. Annual Review of Pathology-Mechanisms of Disease
- Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy
- (2016) Sander Kelderman et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases
- (2016) Qun Lu et al. HUMAN GENETICS
- Association between tumor size and Breslow’s thickness in malignant melanoma
- (2015) David Moreno-Ramírez et al. MELANOMA RESEARCH
- New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice
- (2015) T. Arumugam et al. MOLECULAR CANCER THERAPEUTICS
- Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response
- (2015) M. C. Mihm et al. Cancer Immunology Research
- Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinoma
- (2013) MASAHISA OHTSUKA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CD14+S100A9+Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non–Small Cell Lung Cancer
- (2012) Po-Hao Feng et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours
- (2012) Julia Y S Tsang et al. HISTOPATHOLOGY
- Melanoma-induced immunosuppression and its neutralization
- (2012) Viktor Umansky et al. SEMINARS IN CANCER BIOLOGY
- -Catenin-Dependent Wnt Signaling in C. elegans: Teaching an Old Dog a New Trick
- (2012) B. M. Jackson et al. Cold Spring Harbor Perspectives in Biology
- Complete Functional Segregation of Planarian β-Catenin-1 and -2 in Mediating Wnt Signaling and Cell Adhesion
- (2010) Guoliang Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The catenin family at a glance
- (2010) P. D. McCrea et al. JOURNAL OF CELL SCIENCE
- Rnd3 Regulation of the Actin Cytoskeleton Promotes Melanoma Migration and Invasive Outgrowth in Three Dimensions
- (2009) R. M. Klein et al. CANCER RESEARCH
- Adhesive and Signaling Functions of Cadherins and Catenins in Vertebrate Development
- (2009) E. Stepniak et al. Cold Spring Harbor Perspectives in Biology
- Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton
- (2007) Andrea Hartsock et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now